Published in Life Sci on March 21, 1983
Inhibition of rat heart ornithine decarboxylase by basic polypeptides. Biochem J (1985) 0.75
Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti-D. Transfusion (1996) 2.63
Control of the antitumoral activity of human macrophages produced in large amounts in view of adoptive transfer. Eur J Cancer Clin Oncol (1988) 1.52
Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor. Infect Immun (1987) 1.06
Inhibition of tumor cell proliferation by dimerized ribonuclease. Proc Natl Acad Sci U S A (1976) 1.05
Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase. Cancer Res (1984) 1.01
Pancreatic ribonuclease: enzymic and physiological properties of a cross-linked dimer. Science (1974) 0.95
Hepatic nucleases. 1. Methods for the specific determination and characterization in rat liver. Eur J Biochem (1975) 0.92
Monocyte-derived dendritic cells: development of a cellular processor for clinical applications. Res Immunol (1999) 0.91
Hepatic nucleases. Extrahepatic origin and association of neutral liver ribonuclease with lysosomes. Eur J Biochem (1975) 0.91
Antitumoral effects of lipopolysaccharides, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution. Anticancer Res (1989) 0.89
Antitumor properties of (2R,5R)-6-heptyne-2,5-diamine, a new potent enzyme-activated irreversible inhibitor of ornithine decarboxylase, in rodents. Cancer Res (1984) 0.87
Autologous lymphocytes prevent the death of monocytes in culture and promote, as do GM-CSF, IL-3 and M-CSF, their differentiation into macrophages. J Immunol Methods (1993) 0.86
Enhanced urinary excretion of N1-acetylspermidine and the presence of tumors. Cancer Res (1981) 0.85
Bispecific antibody targeting of human immunodeficiency virus type 1 (HIV-1) glycoprotein 41 to human macrophages through the Fc IgG receptor I mediates neutralizing effects in HIV-1 infection. J Infect Dis (1992) 0.85
In vitro and in vivo antitumor effect of dimerized ribonuclease A. Eur J Cancer (1979) 0.85
Large scale isolation of human blood monocytes by continuous flow centrifugation leukapheresis and counterflow centrifugation elutriation for adoptive cellular immunotherapy in cancer patients. J Immunol Methods (1994) 0.84
Antitumoral properties and reduced toxicity of LPS targeted to macrophages via normal or mannosylated liposomes. Anticancer Res (1990) 0.83
Characterization of subcellular components in synchronized hepatoma cells as a function of the cell cycle. Biochem J (1979) 0.82
Production of human macrophages with potent antitumor properties (MAK) by culture of monocytes in the presence of GM-CSF and 1,25-dihydroxy vitamin D3. Anticancer Res (1993) 0.81
[Localization of a ribonuclease and a polyadenylase in liver mitochondria]. Arch Int Physiol Biochim (1970) 0.81
Antibody-dependent cellular cytotoxicity and neutralization of human immunodeficiency virus type 1 by high affinity cross-linking of gp41 to human macrophage Fc IgG receptor using bispecific antibody. J Gen Virol (1994) 0.81
Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effects. Cancer Immunol Immunother (1991) 0.81
Purification of rat liver particulate neutral ribonuclease and comparison of properties with pancreas and serum ribonucleases. Biochem J (1977) 0.81
Inhibition of the discharge of endocytosed protein from phagosomes into lysosomes in hepatoma cells exposed to dimerized ribonuclease A. Biochem J (1979) 0.81
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma. Cancer Immunol Immunother (2006) 0.80
Hepatic nuclease. 2. Association of polyadenylase, alkaline ribonuclease and deoxyribonuclease with rat-liver mitochondria. Eur J Biochem (1975) 0.80
Explanation of the observation of pancreatic ribonuclease activity at pH 4.5. Int J Pept Protein Res (1977) 0.80
[Ribonuclease activity in the pancreas]. Arch Int Physiol Biochim (1974) 0.78
Polyamine metabolism and polyamine excretion in normal and tumor bearing rodents. Anticancer Res (1985) 0.78
Study of the dependence of human monocytes and macrophages antitumoral properties upon TNF-alpha expression or release. Anticancer Res (1990) 0.78
Functional consequences of monocyte/macrophage infection by HIV1. Res Immunol (1992) 0.78
Establishment and characterization of long-term cultured cell lines of murine resident macrophages. J Leukoc Biol (1988) 0.77
Rat interferon enhances the expression of acetylcholine receptors in rat myotubes in culture. J Neurosci Res (1988) 0.77
Antitumoral potential of aerosolized interferon-gamma in mice bearing lung metastases. Am J Respir Cell Mol Biol (1994) 0.77
Inhibition of protein degradation induced by dimeric ribonuclease A in hepatoma cells [proceedings]. Biochem Soc Trans (1977) 0.76
Effects of cross-linked dimers of ribonuclease A or of lysozyme on the processing of endocytosed peroxidase by hepatoma cells. Biochem J (1982) 0.75
Increase of lysosomal fragility by interferon : evidence for the role of a modification in dynamic properties of the cell membrane involved in the endocytosis process [proceedings]. Arch Int Physiol Biochim (1980) 0.75
[Proceedings: Cytostatic properties of pancreatic ribonuclease A dimer]. Arch Int Physiol Biochim (1976) 0.75
TMA-DPH a fluorescent probe of membrane dynamics in living cells. How to use it in phagocytosis. Cell Biophys (1989) 0.75
Effect of dimerized ribonuclease A on the intracellular localization of exogenous proteins taken up from the culture medium by hepatoma cells [proceedings]. Arch Int Physiol Biochim (1978) 0.75
[Intracellular localization, purification, and characterization of neutral liver ribonuclease in the rat]. Arch Int Physiol Biochim (1973) 0.75
Effect of alpha-monofluoromethyl histidine, an irreversible inhibitor of histidine decarboxylase, on gestation in mice. Contraception (1982) 0.75
Cytostatic effect and inhibition of protein degradation by dimerized lysozyme: comparison with the effect of dimerized ribonuclease and reversibility by galactose [proceedings]. Arch Int Physiol Biochim (1979) 0.75
Establishment and characterization of somatic hybrids between human differentiated macrophages and mouse myeloma NS1 cells. Int J Cell Cloning (1990) 0.75
Treatment of metastatic Lewis lung carcinoma with DL-alpha-difluoromethylornithine. Eur J Cancer Clin Oncol (1983) 0.75
[Plasmatic origin of neutral ribonuclease associated with liver lysosomes]. Arch Int Physiol Biochim (1973) 0.75
Interferon resistance in leukaemic cells and lysosome stability [proceedings]. Biochem Soc Trans (1977) 0.75
Characterization of surface markers of continuously growing murine resident macrophages. J Leukoc Biol (1988) 0.75
Adoptive immunotherapy with bispecific antibodies: targeting through macrophages. Res Immunol (1992) 0.75
[Immunotargeting of tumors: state of the art and prospects in 2000]. Bull Cancer (2000) 0.75
Frequency of human anti-FVIII antibodies in humanized SCID mice elicited by recombinant deleted factor VIII and by a plasma derived factor VIII. J Immunol Methods (1997) 0.75
Analysis of complete cell homogenates of hepatoma by density-gradient centrifugation. Arch Int Physiol Biochim (1976) 0.75